Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.
about
BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cellsSodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin.Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancerDegenerative effect of Cisplatin on testicular germinal epitheliumSpecial Agents Hunting Down Women Silent Killer: The Emerging Role of the p38α Kinase.Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells.Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy.Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancerSafe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsMigration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.Disruption of Mitotic Progression by Arsenic.Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin.Protective Role of GnRH Antagonist on Chemotherapy-induced Spermatogenesis Disorder: A Morphological Study.Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study.
P2860
Q28478390-BA7FCF8A-A259-4B2E-A4DB-7B29BB58E154Q33940195-D564A343-7A7E-4896-8B5B-CFCA51975F9CQ33962540-D38D3DB4-3F97-48B7-A47B-7EDA979C03D3Q34517743-F5432953-9810-4879-A42C-2621BD37C053Q34704011-8D398CB9-A0C8-4AA4-929D-2844F86B9EBFQ35061617-598EAC63-4B31-45AA-AF8D-7ED7AF1D693AQ35864802-BC13A0A0-F7C9-4E3C-B4EC-B72F4FE82A23Q35871264-0E2ABEF6-E129-41B6-B673-682D9637C310Q36472709-EC6B515E-6DD5-430C-9397-D71A79EAA0A0Q36697860-89DFF497-4977-4EC0-AEFB-401DC9A11920Q36880907-717C5470-4ADB-40AE-B2B9-73CF3A440300Q37096241-56E65E71-A183-4A08-9208-DC939B2A2AD8Q37486703-04D3F88A-FC58-4BE7-82BD-D4FBB2CFB593Q37989844-C680A88B-B3B1-46E3-8520-89D2DDD7DA56Q38386478-7119D552-E9F4-40EB-9F72-27BBCEB80F85Q39002643-17FFD75D-F202-4EEC-9A46-142E5D7B2FA2Q42633199-C4276247-A95F-4090-9236-0B6A6BE12885Q47672975-F3DBD8D1-797D-4B82-8F56-A254224B1895
P2860
Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancing the efficacy of cisp ...... t - could arsenic have a role.
@en
Enhancing the efficacy of cisp ...... t - could arsenic have a role.
@nl
type
label
Enhancing the efficacy of cisp ...... t - could arsenic have a role.
@en
Enhancing the efficacy of cisp ...... t - could arsenic have a role.
@nl
prefLabel
Enhancing the efficacy of cisp ...... t - could arsenic have a role.
@en
Enhancing the efficacy of cisp ...... t - could arsenic have a role.
@nl
P2860
P356
P1476
Enhancing the efficacy of cisp ...... nt - could arsenic have a role
@en
P2093
C William Helm
P2860
P2888
P356
10.1186/1757-2215-2-2
P50
P577
2009-01-14T00:00:00Z
P5875
P6179
1024408706